Thus, anti-CD20 therapies, which spare plasma cells but deplete B lymphocytes, are indeed extremely effective in treating multiple sclerosis and, interestingly, the immunosuppressive cytokine IL-10 produced by plasma cells has a protective value when present in multiple sclerosis lesions. This evidence concerns the gene IL10 and multiple sclerosis.